Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's β-amyloid peptide

Keyphrases

• Peptide Inhibitor 100%
• Genetic Evidence 33%
• Oligomer Formation 33%
• Terminal End 33%
• Peptide-based 33%
• Cytotoxic Effect 33%
• KLVFF 33%
• Binding Region 33%
• Self-oligomerization 33%
• Self-association 33%
• Aggregation Inhibitor 33%
• Novel Therapies 33%

Biochemistry, Genetics and Molecular Biology

• Amyloid 100%
• Oligomerization 100%
• N-Terminus 50%
• C-Terminus 50%
• Peptide Sequence 50%
• Cytotoxicity 50%
• Genetics 50%